Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.

Molecular Biology of the Cell
Crystal N MarconettGary L Firestone

Abstract

Estrogen receptor (ER)alpha is a critical target of therapeutic strategies to control the proliferation of hormone-dependent breast cancers. Preferred clinical options have significant adverse side effects that can lead to treatment resistance due to the persistence of active estrogen receptors. We have established the cellular mechanism by which indole-3-carbinol (I3C), a promising anticancer phytochemical from Brassica vegetables, ablates ERalpha expression, and we have uncovered a critical role for the GATA3 transcription factor in this indole-regulated cascade. I3C-dependent activation of the aryl hydrocarbon receptor (AhR) initiates Rbx-1 E3 ligase-mediated ubiquitination and proteasomal degradation of ERalpha protein. I3C inhibits endogenous binding of ERalpha with the 3'-enhancer region of GATA3 and disrupts endogenous GATA3 interactions with the ERalpha promoter, leading to a loss of GATA3 and ERalpha expression. Ectopic expression of GATA3 has no effect on I3C-induced ERalpha protein degradation but does prevent I3C inhibition of ERalpha promoter activity, demonstrating the importance of GATA3 in this I3C-triggered cascade. Our preclinical results implicate I3C as a novel anticancer agent in human cancers that coexpres...Continue Reading

References

Feb 26, 1999·The Journal of Biological Chemistry·J M Grégoire, P H Roméo
Mar 30, 1999·International Journal of Cancer. Journal International Du Cancer·R V HochR J Weigel
May 18, 1999·Molecular and Cellular Biology·F CharronM Nemer
Aug 14, 1999·Journal of Internal Medicine·E Enmark, J A Gustafsson
Aug 10, 2000·Journal of Mammary Gland Biology and Neoplasia·W P Bocchinfuso, K S Korach
May 8, 2001·Archives of Biochemistry and Biophysics·C A RichterM Hannink
Feb 19, 2002·Chemical Research in Toxicology·Richard E StaubLeonard F Bjeldanes
Jul 4, 2003·The Journal of Nutrition·Karen J AubornTimothy H Carter
Oct 25, 2003·Oncogene·Robert ClarkeLeena A Hilakivi-Clarke
Dec 6, 2003·The American Journal of Surgical Pathology·Abeer M ShaabanChristopher S Foster
Feb 20, 2004·Journal of Mammary Gland Biology and Neoplasia·S Ali, R C Coombes
Apr 20, 2004·British Journal of Cancer·C K OsborneR I Nicholson
Jan 7, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Dagmara S AntkiewiczWarren Heideman
Feb 1, 2005·The Journal of Nutritional Biochemistry·Young S Kim, J A Milner
Apr 30, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Jorge R Pasqualini, Gérard S Chetrite
Aug 6, 2005·Cell Cycle·Bharat B Aggarwal, Haruyo Ichikawa
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James D BrentonCarlos Caldas
Feb 21, 2006·The Journal of Nutritional Biochemistry·Thomas T Y WangYoung S Kim
Dec 26, 2006·Nature Cell Biology·Marie-Liesse Asselin-LabatJane E Visvader
Feb 24, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jane V HigdonRoderick H Dashwood
Mar 21, 2007·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Rama GarimellaH Clarke Anderson
Mar 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Catherine M EakinRachel E Klevit
Mar 30, 2007·Nature·Fumiaki OhtakeShigeaki Kato
Dec 25, 2007·Médecine sciences : M/S·Marie-Liesse Asselin-Labat
Jan 29, 2008·Current Medicinal Chemistry·Eric BadiaVincent Cavaillès
Mar 4, 2008·Cancer Letters·Jing-Ru WengChing-Shih Chen
Mar 25, 2008·Current Opinion in Cell Biology·Hosein Kouros-MehrZena Werb
Apr 11, 2008·Taiwanese Journal of Obstetrics & Gynecology·Wen-Ling LeePeng-Hui Wang
May 27, 2008·Cancer Letters·Stephen SafeSudhakar Chintharlapalli

❮ Previous
Next ❯

Citations

May 29, 2013·Biochimica Et Biophysica Acta·Shaolong FengXinming Wang
Jun 5, 2013·Nutrition Reviews·Philip B BusbeePrakash S Nagarkatti
Mar 1, 2013·Cancer Prevention Research·Abby D Benninghoff, David E Williams
Jun 28, 2016·Journal of Acupuncture and Meridian Studies·Abhishek ThakurSugato Banerjee
Nov 20, 2014·Computational and Structural Biotechnology Journal·Martin Krøyer Rasmussen, Galia Zamaratskaia
Mar 15, 2011·The Journal of Steroid Biochemistry and Molecular Biology·Fumiaki OhtakeShigeaki Kato
May 6, 2014·Nucleic Acids Research·Jinho LeeGábor Balázsi
Jan 30, 2015·Critical Reviews in Food Science and Nutrition·Venkidasamy BaskarShivraj Hariram Nile
Jul 29, 2016·Journal of Cell Communication and Signaling·Soujanya D YelamanchiKanchan Kumar Mukherjee
Aug 12, 2014·BMC Complementary and Alternative Medicine·Sylvin Benjamin AtebaLiselotte Krenn
Jun 20, 2012·World Journal of Experimental Medicine·Jiao Wang, Yang-Fu Jiang
Oct 5, 2017·International Journal of Cancer. Journal International Du Cancer·Lokesh Dalasanur NagaprashanthaSharad S Singhal
Jan 16, 2019·Expert Opinion on Drug Metabolism & Toxicology·Patrick TarnowAndreas Luch
Jun 5, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Troy D HubbardGary H Perdew
Jan 17, 2021·International Journal of Molecular Sciences·Marco GargaroFrancesca Fallarino
May 25, 2021·Frontiers in Pharmacology·Sylvin Benjamin AtebaLiselotte Krenn
Jun 5, 2021·Neurobiology of Disease·Miguel A PappollaBurkhard Poeggeler
May 27, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Monica L Vermillion MaierDavid E Williams

❮ Previous
Next ❯

Methods Mentioned

BETA
transfections
biopsies
immunoprecipitations
transfection
PCR
Immunoprecipitation
ChIP
Ubiquitination
nuclear translocation

Software Mentioned

UCSC Genome Browser
TFSearch
Photoshop

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.